The Incidence and Risk Factors of Chronic Pulmonary Infection after Radiotherapy in Patients with Lung Cancer
Cancer Research and Treatment · 2023
DOI: 10.4143/crt.2022.1305 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Research and Treatment, 2023. Verfasst von Yeonseok Choi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Kyung Hee University Hospital, Kyung Hee University Coll…. Hauptthemen laut MEDLINE: Lung Neoplasms, Radiotherapy. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Purpose
This study aimed to investigate cumulative incidence and risk factors associated with chronic pulmonary infection (CPI) development after radiotherapy for lung cancer.Materials and Methods We retrospectively analyzed 1,872 patients with lung cancer who received radiotherapy for lung cancer from 2010-2014, had a follow-up period of ≥ 3 months after radiotherapy, and did not have CPI at the time of radiotherapy. CPI was defined as pulmonary tuberculosis, non-tuberculous mycobacterial pulmonary disease, chronic pulmonary aspergillosis, or pulmonary actinomycosis. The cumulative incidence of CPI and overall survival (OS) were estimated using the Kaplan-Meier method, and a multivariable Cox proportional hazards analysis was performed to identify risk factors associated with CPI development.
Results
The median follow-up period was 2.3 years with OS rates of 55.6% and 37.6% at 2 and 5 years, respectively. CPI developed in 59 patients at a median of 1.8 years after radiotherapy, with cumulative incidence rates of 1.1%, 3.4%, 5.0%, and 6.8% at 1, 3, 5, and 7 years, respectively. A lower body mass index, interstitial lung disease, prior pulmonary tuberculosis, larger clinical target volume, history of lung cancer surgery or radiation pneumonitis, and use of inhaled corticosteroids were independent risk factors for CPI development.
Conclusion
The long-term survival rate of lung cancer patients receiving radiotherapy was not low, but the cumulative incidence of CPI gradually increased to 6.8% at 7 years after radiotherapy. Therefore, close monitoring of CPI development is required in surviving patients with risk factors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Kyung Hee University Hospital, Kyung Hee University College of Medicine, Seoul, Korea.
- Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
- Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Förderung
- National Research Foundation of Korea
Zitieren
APA
Choi, Y., Noh, J. M., Shin, S. H., Lee, K., Um, S. W., Kim, H., Pyo, H., Ahn, Y. C., & Jeong, B. H. (2023). The Incidence and Risk Factors of Chronic Pulmonary Infection after Radiotherapy in Patients with Lung Cancer. Cancer Research and Treatment. https://doi.org/10.4143/crt.2022.1305
Vancouver
Choi Y, Noh JM, Shin SH, Lee K, Um SW, Kim H, et al. The Incidence and Risk Factors of Chronic Pulmonary Infection after Radiotherapy in Patients with Lung Cancer. Cancer Research and Treatment. 2023. doi:10.4143/crt.2022.1305
BibTeX
@article{Choi2023,
author = {Choi, Yeonseok and Noh, Jae Myoung and Shin, Sun Hye and Lee, Kyungjong and Um, Sang-Won and Kim, Hojoong and Pyo, Hongryull and Ahn, Yong Chan and Jeong, Byeong-Ho},
title = {The Incidence and Risk Factors of Chronic Pulmonary Infection after Radiotherapy in Patients with Lung Cancer},
journal = {Cancer Research and Treatment},
year = {2023},
doi = {10.4143/crt.2022.1305}
}
EUVIMED